VeraMorph

About VeraMorph

VeraMorph is dedicated to prolonging and improving the quality of life for patients across various indications. The company is driven by a team of experienced entrepreneurs and executives with expertise in drug delivery and product design, aiming to develop more efficacious therapies.

Products & Services

Oral Drug Delivery Platform:A proprietary platform to improve and accelerate clinical translation of poorly soluble lead compounds.

Research & Development:Focused on advancing drug delivery technologies.

Oral Drug Products:A portfolio of clinically-differentiated oral versions of approved drugs.

Specialties

Drug Delivery Product Design Oral Drug Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Fast Track Grant T: - FT: SBIR Fast Track Grant	A: 5000000 MR: - FA: roughly $5M FAN: 5000000	D: 2025-10-15 FD: 2025-10-15	1 investors

SBIR Fast Track Grant Latest

2025-10-15

$5.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Doug Godfrin

Founder & CEO

C

Colin Minchom

VP of Manufacturing

R

Ray Forslund

VP of Regulatory

Recent News

VeraMorph Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised